The crystal structure of the heterocyclic compound 2-(4-methoxyphenyl)-7-phenylpyrazolo[1,5-c]pyrimidine, C19H15N3O, has been determined and its self-assembly on the surface of graphite has been examined using atomic force microscopy (AFM). The title compound crystallized in the monoclinic space group P21/c, with two independent molecules in the asymmetric unit. The packing of the L-shaped molecules in the crystal is governed by arene interactions, in the absence of any conventional hydrogen-bonding interactions. The packing arrangement reveals four types of dimeric motifs stabilized by π–π and C—H...π interactions. At low coverage, molecules assemble into long needle-like islands on the graphite surface. High-resolution AFM images reveal that the molecules interact through weak noncovalent interactions between the aromatic H atoms and the methoxy O atoms.
The crystal structure of methyl-I 6, nor-5-hydroxy-6,7,15-trioxo dehydroabietate has been determined from three-dimensional X-ray diffraction data. The compound crystallizes in the orthorhombic space group P2,2,2 with unit cell parameters a = 19.226(3) 8,, b = 11.075(3) A, c = 8.375(2) A, Z = 4, V = 1783.3(7) A3, do = 1.36 g~m -~. The gross structure was determined by direct methods which on refinement yielded a final value of R index as 0.038. Ring A is a chair, ring B an envelope whereas the ring C adopts a strictly planar conformation. The rings A and B are trans fused. The ester group at C 4 is cis fused to methyl carbon C15 whereas another methyl carbon C18 and 0x0 O(15) of the isopropyl group at C13 are rotated to positions 0.!07(3) 8, and 0.179(2) A out of the plane of ring C.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.